Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Got A Better Idea? US FDA Seeks Help Tackling Ethylene Oxide Troubles

Executive Summary

Regulators are reaching out to industry and the public-at-large for ideas that would help develop new sterilization methods that could reduce or replace the need for ethylene oxide used to treat difficult-to-clean medical devices. They are also looking for ways to reduce the risk and environmental impact of the sterilizing agent.

You may also be interested in...



Risk Of Sterilization Plant Shutdowns Across US Sends Shockwave Through Industry

While a number of US states are taking actions that could potentially ban or limit ethylene oxide (EtO) sterilization plants in their communities, the FDA, industry and others are raising the alarm that such moves could lead to a shortage of medical devices critical to patients.

BD, State Of Georgia Agree To Allow EtO Sterilization Plant To Keep Operating, Averting Potential Device Shortage

The state’s environmental regulators agreed on 28 October to allow Becton Dickinson to continue sterilizing medical devices using ethylene oxide (EtO) as long as the company continues to make modifications to their sterilization plants in the state, and limit the number of devices they sterilize. The agreement may have averted a serious medical device shortage across the US.

Device Sterilization, Duodenoscopes Focus Of Planned Meeting

The US FDA is asking stakeholders to weigh in on a common device sterilization procedure and the contagion risks of reprocessed duodenoscopes ahead of a November panel meeting.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT125380

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel